The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II telemedicine study of pemigatinib in adult patients with unresectable or metastatic pancreas cancer with FGFR2 gene fusions or other FGFR genetic alterations.
 
Zachary Risch
Stock and Other Ownership Interests - Alnylam; Geron; Lineage Cell Therapeutics; Oncolytics; Pfizer; Repligen; Sangamo Therapeutics; Viatris
 
Michele Wing
No Relationships to Disclose
 
Julie Reeser
No Relationships to Disclose
 
Leah Stein
No Relationships to Disclose
 
Thuy Dao
No Relationships to Disclose
 
Amy Smith
No Relationships to Disclose
 
Eric Samorodnitsky
No Relationships to Disclose
 
Anoosha Paruchuri
No Relationships to Disclose
 
Xueliang Jeff Pan
No Relationships to Disclose
 
Sameek Roychowdhury
Stock and Other Ownership Interests - Johnson & Johnson (I)
Honoraria - Illumina; Integrated DNA Technologies
Consulting or Advisory Role - AbbVie; Incyte; Incyte; Merck; QED Therapeutics; Seagen
Research Funding - Ignyta; Incyte; QED Therapeutics; Takeda